Helse Vest in Nor­way invests in Medanets after a suc­cess­ful pilot

Senior Advi­sor Trond Waehle from Helse Vest IKT pre­sent­ed the pilot results at the Medanets User Days 2026. Based on the eval­u­a­tion, the region­al board approved the invest­ment in Medanets for clin­i­cal use. Helse Vest is cur­rent­ly plan­ning the roll­out of the solu­tion across the region and extend­ing the usage to addi­tion­al fea­tures not includ­ed in the pilot.

Medanets was pilot­ed with our part­ner Mesalvo’s EHR solu­tion, which has been in place at Helse Vest since a decade. The pilot uti­lized Mesalvo’s Health­Cen­tre Cor­tex tech­nol­o­gy with Medanets. The pilot­ed scope includ­ed mobile Ear­ly Warn­ing Score, vital signs and pain assess­ment using Obser­va­tion val­ues, and admin­is­tra­tion of med­ica­tions. 150 nurs­es pilot­ed the fea­tures for about six months using iPhones and our Next Lev­el iOS app.

Coop­er­a­tion between the involved par­ties ensured smooth progress

“The com­bi­na­tion of a brand-new iOS app from Medanets and the first instal­la­tion for Mesal­vo with inte­gra­tion into the app meant that the peri­od lead­ing up to the pilot start was as much a devel­op­ment project as an imple­men­ta­tion project”, says Waehle. “How­ev­er, good coop­er­a­tion and the will­ing­ness of every­one involved to solve prob­lems made the project run smooth­ly. Close dai­ly con­tact with Mesal­vo and Medanets teams dur­ing the first phase of the pilot meant that we were able to quick­ly cor­rect any bugs that were dis­cov­ered”, he adds.

Pur­chase deci­sion was backed with evi­dence

To sum­marise the pilot, Waehle’s team pre­pared an eval­u­a­tion report based on a quan­ti­ta­tive sur­vey. The sur­vey was con­duct­ed by Advi­sor Iljen Rosse­myr as part of her master’s the­sis in Health Infor­mat­ics, and was designed accord­ing to a the­o­ret­i­cal frame­work, the infor­ma­tion sys­tems suc­cess mod­el from Delone and McLean. The sur­vey con­sist­ed of 31 struc­tured ques­tions, of which respon­dents were required to answer 28, on a five-point Lik­ert scale in rela­tion to giv­en state­ments, 1 mean­ing “strong­ly dis­agree” and 5 mean­ing “strong­ly agree”. In addi­tion, the team looked at stud­ies and reports from oth­er hos­pi­tals regard­ing Medanets usabil­i­ty and asso­ci­at­ed ben­e­fits, as well as the organisation’s own strat­e­gy doc­u­ments.

The results from the eval­u­a­tion in Helse Vest are in line with, and part­ly con­sis­tent with, expe­ri­ences with Medanets from oth­er hos­pi­tals in Nor­way, Swe­den, Fin­land and the UK.  Accord­ing to the eval­u­a­tion team, the find­ings across these con­texts sup­port the same inter­pre­ta­tion: that point-of-care doc­u­men­ta­tion on a mobile app saves time, improves work­flows, enables faster avail­abil­i­ty of clin­i­cal data and sup­ports the deci­sion-mak­ing of health­care per­son­nel.

The eval­u­a­tion team found that the intro­duc­tion of the Medanets app cor­re­sponds well to the over­all strat­e­gy of Helse Vest, as it will pro­vide increased point-of-care doc­u­men­ta­tion, strength­ened patient safe­ty and more effi­cient use of health­care per­son­nel resources.

“This is the first app I have used that actu­al­ly saves time in my dai­ly work”

The sur­vey results were gen­er­al­ly very pos­i­tive for Medanets. Both sys­tem and infor­ma­tion qual­i­ty of the app received good scores from the respon­dents. For instance, 95% of the respon­dents agreed or strong­ly agreed that the app is easy for new users to learn. 84% of them agreed or strong­ly agreed that the app safe­guards and strength­ens patient safe­ty, includ­ing through ID scan­ning of patient wrist­bands.

86% of the respon­dents agreed or strong­ly agreed that using Medanets pro­vides more time for patient-cen­tred work. This was high­light­ed in one of the respon­dents’ com­ments: “So far, I have only used Medanets to per­form NEWS, and this is the first appli­ca­tion I have used that actu­al­ly saves time in my dai­ly work.”

User sat­is­fac­tion was gen­er­al­ly high, with will­ing­ness to extend the usage of the app to addi­tion­al fea­tures and work­flows.

Source (text and image): Medanets